Skip to main content
. Author manuscript; available in PMC: 2013 Dec 8.
Published in final edited form as: JAMA Surg. 2013 May;148(5):10.1001/jamasurg.2013.1335. doi: 10.1001/jamasurg.2013.1335

Figure 3.

Figure 3

Overall survival probability for patients with and patients without recurrence. Kaplan-Meier overall survival curves show the number of months after diagnosis of survival. Patients with a negative sentinel lymph node biopsy (SLNB) result who experienced recurrence had an overall 5-year survival probability of 68%, and patients with a negative SLNB result who did not experience recurrence had an overall 5-year survival probability of 98%. The overall 5-year survival probability for patients with a negative SLNB result is 91%.